124 related articles for article (PubMed ID: 29560102)
1. Detection of circulating tumor DNA in patients with osteosarcoma.
Barris DM; Weiner SB; Dubin RA; Fremed M; Zhang X; Piperdi S; Zhang W; Maqbool S; Gill J; Roth M; Hoang B; Geller D; Gorlick R; Weiser DA
Oncotarget; 2018 Feb; 9(16):12695-12704. PubMed ID: 29560102
[TBL] [Abstract][Full Text] [Related]
2. Next Generation Sequencing of Tumor and Matched Plasma Samples: Identification of Somatic Variants in ctDNA From Ovarian Cancer Patients.
Barbosa A; Pinto P; Peixoto A; Guerra J; Pinheiro M; Santos C; Pinto C; Escudeiro C; Bartosch C; Santos R; Brandão A; Silva J; Teixeira MR
Front Oncol; 2021; 11():754094. PubMed ID: 34660321
[TBL] [Abstract][Full Text] [Related]
3. Circulating tumor DNA shows variable clonal response of breast cancer during neoadjuvant chemotherapy.
Kim JY; Park D; Son DS; Nam SJ; Kim SW; Jung HH; Kim YJ; Park G; Park WY; Lee JE; Park YH
Oncotarget; 2017 Oct; 8(49):86423-86434. PubMed ID: 29156805
[TBL] [Abstract][Full Text] [Related]
4. Detection of circulating tumor DNA in patients with advanced non-small cell lung cancer.
Yao Y; Liu J; Li L; Yuan Y; Nan K; Wu X; Zhang Z; Wu Y; Li X; Zhu J; Meng X; Wei L; Chen J; Jiang Z
Oncotarget; 2017 Jan; 8(2):2130-2140. PubMed ID: 27791985
[TBL] [Abstract][Full Text] [Related]
5. Correlation of genomic alterations assessed by next-generation sequencing (NGS) of tumor tissue DNA and circulating tumor DNA (ctDNA) in metastatic renal cell carcinoma (mRCC): potential clinical implications.
Hahn AW; Gill DM; Maughan B; Agarwal A; Arjyal L; Gupta S; Streeter J; Bailey E; Pal SK; Agarwal N
Oncotarget; 2017 May; 8(20):33614-33620. PubMed ID: 28431395
[TBL] [Abstract][Full Text] [Related]
6. Carrier molecules and extraction of circulating tumor DNA for next generation sequencing in colorectal cancer.
Beránek M; Sirák I; Vošmik M; Petera J; Drastíková M; Palička V
Acta Medica (Hradec Kralove); 2016; 59(2):54-8. PubMed ID: 27526306
[TBL] [Abstract][Full Text] [Related]
7. Detection of Somatic Structural Variants Enables Quantification and Characterization of Circulating Tumor DNA in Children With Solid Tumors.
Klega K; Imamovic-Tuco A; Ha G; Clapp AN; Meyer S; Ward A; Clinton C; Nag A; Van Allen E; Mullen E; DuBois SG; Janeway K; Meyerson M; Thorner AR; Crompton BD
JCO Precis Oncol; 2018; 2018():. PubMed ID: 30027144
[TBL] [Abstract][Full Text] [Related]
8. Detection of
Ratajska M; Koczkowska M; Żuk M; Gorczyński A; Kuźniacka A; Stukan M; Biernat W; Limon J; Wasąg B
Oncotarget; 2017 Nov; 8(60):101325-101332. PubMed ID: 29254167
[TBL] [Abstract][Full Text] [Related]
9. Quantification of mutant alleles in circulating tumor DNA can predict survival in lung cancer.
Yang X; Zhuo M; Ye X; Bai H; Wang Z; Sun Y; Zhao J; An T; Duan J; Wu M; Wang J
Oncotarget; 2016 Apr; 7(15):20810-24. PubMed ID: 26989078
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Possibility to Detect Circulating Tumor DNA From Pituitary Adenoma.
Megnis K; Peculis R; Rovite V; Laksa P; Niedra H; Balcere I; Caune O; Breiksa A; Nazarovs J; Stukens J; Konrade I; Pirags V; Klovins J
Front Endocrinol (Lausanne); 2019; 10():615. PubMed ID: 31620080
[No Abstract] [Full Text] [Related]
11. TumorNext: A comprehensive tumor profiling assay that incorporates high resolution copy number analysis and germline status to improve testing accuracy.
Gray PN; Vuong H; Tsai P; Lu HM; Mu W; Hsuan V; Hoo J; Shah S; Uyeda L; Fox S; Patel H; Janicek M; Brown S; Dobrea L; Wagman L; Plimack E; Mehra R; Golemis EA; Bilusic M; Zibelman M; Elliott A
Oncotarget; 2016 Oct; 7(42):68206-68228. PubMed ID: 27626691
[TBL] [
